Non-small cell lung cancer
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
84
Arm 1: with twice-daily thoracic radiotherapy daily 1.5gy/fr. bid, total 45gy(30fr during 3weeks) Arm 2: with once-daily thoracic radiotherapy daily 2.4gy/fr. qd, total 60gy(25fr during 5weeks)
National Cancer Canter, Korea
Ilsan-ro 323, Ilsandoung-gu, Goyang-si, Gyeonggi-do, South Korea
RECRUITINGNational Cancer Canter, Korea
Ilsan-ro 323, Ilsandoung-gu, Goyang-si, Gyeonggi-do, South Korea
RECRUITINGprogression free survival
Time frame: 5years after chemoradiotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.